Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancer.

Introduction: The introduction of targeted drugs has had a significant impact on the approach to assessing tumour response. These drugs often induce a rapid cytostatic effect associated with a less pronounced and slower tumoural volume reduction, thereby impairing the correlation between the absence...

Descripción completa

Detalles Bibliográficos

Publicado en:	European Journal of Nuclear Medicine & Molecular Imaging Vol. 43; no. 10; pp. 1792 - 1802
Autores principales:	Woff, Erwin, Hendlisz, Alain, Garcia, Camilo, Deleporte, Amelie, Delaunoit, Thierry, Maréchal, Raphaël, Holbrechts, Stéphane, Eynde, Marc, Demolin, Gauthier, Vierasu, Irina, Lhommel, Renaud, Gauthier, Namur, Guiot, Thomas, Ameye, Lieveke, Flamen, Patrick
Formato:	Journal Article
Publicado:	Springer Nature Sep2016
Acceso en línea:	Ver este registro en EBSCOhost